Opinion - (2025) Volume 16, Issue 1
Received: 29-Jan-2025, Manuscript No. hgec-25-164245;
Editor assigned: 31-Jan-2025, Pre QC No. P-164245;
Reviewed: 14-Feb-2025, QC No. Q-164245;
Revised: 19-Feb-2025, Manuscript No. R-164245;
Published:
26-Feb-2025
, DOI: 10.37421/2161-0436.2025.16.272
Citation: Poulin, Betancor. “Assessing the Prognostic Impact of Strain Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy Using Speckle Tracking Echocardiography.” Human Genet Embryol 16 (2025): 272.
Copyright: © 2025 Poulin B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
ARVC is primarily a genetically inherited disorder, with autosomal dominant inheritance being the most common mode of transmission. Mutations in several genes, including those encoding desmosomal proteins such as plakophilin-2, desmoglein-2, and desmocollin-2, are implicated in the disease's pathogenesis. These mutations disrupt the intercellular junctions that hold cardiac myocytes together, leading to myocardial apoptosis, inflammation, and replacement of the myocardium by fibrous and fatty tissue. The right ventricle is most commonly affected in ARVC due to its thinner myocardium, which is more susceptible to the deleterious effects of these mutations. As the disease progresses, fibrofatty infiltration of the RV myocardium leads to ventricular arrhythmias, most notably Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF), which can result in sudden cardiac death. The left ventricle can also be involved in later stages of the disease, though the right ventricle remains the primary site of pathological changes. Structural changes in ARVC, such as right ventricular dilation, regional wall motion abnormalities, and thinning of the myocardium, are often detectable using conventional imaging modalities like echocardiography, Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). However, these structural changes may not always correlate with functional impairment, especially in the early stages of the disease. Therefore, functional imaging techniques like speckle tracking echocardiography, which assesses myocardial strain, have become increasingly important for early detection and risk stratification in ARVC [2].
Speckle Tracking Echocardiography (STE) is an advanced imaging technique that allows for the assessment of myocardial deformation in multiple directions, including longitudinal, circumferential, and radial strain. Unlike conventional echocardiography, which provides information on the motion of the heart walls, STE analyzes the movement of myocardial speckles (natural acoustic markers in the tissue) and quantifies the deformation or strain in the myocardium during the cardiac cycle. The use of STE in ARVC provides a unique advantage because it enables the detection of subtle myocardial dysfunction before significant structural changes are evident. In ARVC, early myocardial involvement often occurs without apparent regional wall motion abnormalities, making conventional echocardiography less sensitive for identifying early disease. However, STE can detect impaired myocardial strain, even in the absence of overt structural abnormalities, and therefore provides critical information for early diagnosis and prognosis.
The prognostic impact of strain imaging in ARVC lies in its ability to assess the severity and extent of myocardial dysfunction, which is crucial for predicting clinical outcomes, including the risk of arrhythmias, heart failure, and sudden cardiac death. Several studies have demonstrated that strain measurements obtained from STE can provide valuable information about the progression of ARVC and help predict adverse events [3].
One of the key challenges in managing ARVC is the ability to detect myocardial dysfunction at an early stage, especially before structural changes are visible on conventional imaging. STE has proven to be sensitive in identifying early myocardial impairment in the right ventricle, even when the patient has no overt symptoms or wall motion abnormalities. Impaired myocardial strain, particularly in the right ventricular free wall, is often one of the earliest indicators of disease progression. Studies have shown that Right Ventricular Longitudinal Strain (RVLS) is significantly reduced in patients with ARVC compared to healthy controls. This reduction in RVLS occurs before any significant dilation or thinning of the right ventricle is detectable, making it a valuable early marker for subclinical disease. Monitoring RVLS over time can help track disease progression and identify patients at higher risk of developing symptomatic heart failure or arrhythmias. Ventricular arrhythmias, including VT and VF, are the hallmark of ARVC and are the leading cause of sudden cardiac death in affected individuals. The ability to predict arrhythmic events is critical for determining appropriate treatment strategies, such as the use of Implantable Cardioverter-Defibrillators (ICDs) or antiarrhythmic therapy. STE can play a role in risk stratification by assessing myocardial strain and identifying areas of the right ventricle that are more prone to arrhythmogenic remodeling. Impaired myocardial strain in the right ventricle is often associated with increased arrhythmic risk in ARVC. For example, studies have demonstrated that patients with significant reduction in RVLS have a higher likelihood of experiencing sustained VT or requiring ICD implantation. Additionally, the presence of regional strain abnormalities in the right ventricle, particularly in areas with fibro-fatty infiltration, has been linked to a higher risk of arrhythmias. Therefore, STE can help identify patients who may benefit from more aggressive treatment or closer monitoring [4].
As ARVC progresses, the right ventricle becomes increasingly dilated and dysfunctional, leading to right-sided heart failure. Although conventional echocardiography can identify gross changes in RV size and function, STE offers more sensitive and quantitative data on myocardial deformation, allowing for a better assessment of the severity of functional impairment. This is particularly important for predicting the onset of heart failure and guiding treatment decisions. Studies have shown that reduced RV strain is associated with a worse prognosis in ARVC, including a higher risk of heart failure symptoms and reduced exercise capacity. In some cases, the progression of myocardial dysfunction can be identified through changes in strain imaging before clinical symptoms appear. Monitoring strain over time can help clinicians track the diseaseâ??s progression and make more informed decisions regarding interventions [5].
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Human Genetics & Embryology received 309 citations as per Google Scholar report